The Weekly Litigation News Digest is now live. Subscribe now

Crenolanib For Treating Flt3 Mutated Proliferative Disorders - EP2941251

The patent EP2941251 was granted to Arog Pharmaceuticals on Mar 7, 2018. The application was originally filed on Oct 14, 2013 under application number EP13869984A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2941251

AROG PHARMACEUTICALS
Application Number
EP13869984A
Filing Date
Oct 14, 2013
Status
Opposition Rejected
May 9, 2025
Publication Date
Mar 7, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HEXAL PHARMADec 7, 2018KRAUS & LEDERERADMISSIBLE
HEXAL PHARMADec 7, 2018KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004049032
DESCRIPTIONUS2005124599
DESCRIPTIONUS5990146
DESCRIPTIONUS7183414
DESCRIPTIONWO0140217
DESCRIPTIONWO02092599
DESCRIPTIONWO0232861
DESCRIPTIONWO03024931
DESCRIPTIONWO03024969
DESCRIPTIONWO03035009
DESCRIPTIONWO03037347
DESCRIPTIONWO03057690
DESCRIPTIONWO03099771
DESCRIPTIONWO2004005281
DESCRIPTIONWO2004016597
DESCRIPTIONWO2004018419
DESCRIPTIONWO2004039782
DESCRIPTIONWO2004043389
DESCRIPTIONWO2004046120
DESCRIPTIONWO2004058749
DESCRIPTIONWO9916755

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents